NIT
KYNB

NumerixS Investment Technologies’s Kyntra Bio KYNB Stock Holding History

NumerixS Investment Technologies’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-48
Closed -$51K – 1085
2019
Q4 		$51K Buy
+48
New +$49K 0.01% 814
2017
Q3 		– Sell
-356
Closed -$287K – 1214
2017
Q2 		$287K Sell
356
-24
-6% -$16.7K 0.04% 508
2017
Q1 		$234K Buy
+380
New +$231K 0.03% 669
2016
Q4 		– Sell
-292
Closed -$151K – 1183
2016
Q3 		$151K Buy
292
+154
+112% +$72.5K 0.02% 755
2016
Q2 		$57K Buy
+138
New +$63.2K 0.01% 945

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

NumerixS Investment Technologies's KYNB Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 48 shares — an estimated $51K sold.

NumerixS Investment Technologies first reported a position in KYNB in Q2 2016 and held it in 5 quarters. The position peaked at $287K in Q2 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 48 Kyntra Bio shares in Q1 2020, an estimated $51K.
  • NumerixS Investment Technologies first reported a position in Kyntra Bio in Q2 2016 and held it in 5 quarters.
  • NumerixS Investment Technologies's Kyntra Bio position peaked at $287K in Q2 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.